ATMP Sweden is a national network of stakeholders brought together with the common goal of revolutionary patient solutions within ATMP (gene and cell therapy products). Through the essential collaboration of researchers, healthcare and industry ATMP Sweden partners work together to identify challenges and limitations within ATMP development and create novel solutions through research and process development. ATMP Sweden strives to be not only a National but International source of information and support in the development of ATMPs, expansion of the ATMP industry and thus novel solutions for patients. We invite you to join us in working to improve health by accelerating development of innovative, cost effective and safe cell and gene therapy products, while ensuring availability to patients in need.
Company Details
- Employees
- 8
- Founded
- 2018
- Address
- Hälsovägen 7, Plan 3,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- atmpsweden.se
- Keywords
- Advanced Therapy Medicinal Products, ATMP Cell Therapy, Gene Therapy, GMP manufacture, ATMP regulation, law and ethics, CAR-T, Health economy and reimbursement, Clinical trials.
- HQ
- Huddinge, Stockholm
Atmp Sweden Questions
Atmp Sweden's website is atmpsweden.se
Atmp Sweden's LinkedIn profile is https://se.linkedin.com/company/atmpsweden
Atmp Sweden has
8 employees.
View email and phone details for 8
employees at Atmp Sweden.
Atmp Sweden's industry is
Biotechnology Research
Atmp Sweden's top competitors are
Asgard Therapeutics,
Nextcell Pharma Ab,
Bioarctic,
Ccrm Nordic,
Biolamina,
Anocca,
Swedenbio,
Smartcella Holding Ab,
Affibody Ab,
Northx Biologics.
Atmp Sweden's categories are Biotechnology Research
Atmp Sweden's founding year is 2018
